JIYEON JUNG: Open Payments
NPI 1104075308 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 127 payments from 22 companies in 2025. Trend: 2023 $1,941 · 2024 $2,206 · 2025 $2,336
Food & beverage: $2,327Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $308 |
| AstraZeneca Pharmaceuticals LP | 9 | $247 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $246 |
| ABBVIE INC. | 21 | $245 |
| Lilly USA, LLC | 11 | $213 |
| Otsuka America Pharmaceutical, Inc. | 7 | $157 |
| Exact Sciences Corporation | 6 | $147 |
| GlaxoSmithKline, LLC. | 10 | $144 |
| PFIZER INC. | 12 | $143 |
| Corcept Therapeutics | 5 | $83 |
Products named: Kerendia, VRAYLAR, MOUNJARO, REXULTI, BREZTRI, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
